Published in JAMA on December 11, 2013
Mortality among hospitalized Medicare beneficiaries in the first 2 years following ACGME resident duty hour reform. JAMA (2007) 5.81
Mortality among patients in VA hospitals in the first 2 years following ACGME resident duty hour reform. JAMA (2007) 5.50
Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol (2007) 5.14
Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med (2002) 4.38
Characteristics associated with differences in survival among black and white women with breast cancer. JAMA (2013) 3.35
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res (2007) 2.25
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci Transl Med (2012) 2.22
Racial disparities in operative procedure time: the influence of obesity. Anesthesiology (2013) 2.13
Combining propensity score matching and group-based trajectory analysis in an observational study. Psychol Methods (2007) 2.02
Did duty hour reform lead to better outcomes among the highest risk patients? J Gen Intern Med (2009) 1.92
Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev (2010) 1.90
Influence of patient and hospital characteristics on anesthesia time in medicare patients undergoing general and orthopedic surgery. Anesthesiology (2007) 1.87
Prolonged hospital stay and the resident duty hour rules of 2003. Med Care (2009) 1.79
Hospital teaching intensity, patient race, and surgical outcomes. Arch Surg (2009) 1.65
Medical and financial risks associated with surgery in the elderly obese. Ann Surg (2012) 1.61
Effect of the 2010 Chilean earthquake on posttraumatic stress: reducing sensitivity to unmeasured bias through study design. Epidemiology (2013) 1.58
The Hospital Compare mortality model and the volume-outcome relationship. Health Serv Res (2010) 1.46
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.46
Estimating anesthesia and surgical procedure times from medicare anesthesia claims. Anesthesiology (2007) 1.41
Changes in prognosis after the first postoperative complication. Med Care (2005) 1.35
Preoperative antibiotics and mortality in the elderly. Ann Surg (2005) 1.28
Length of stay, conditional length of stay, and prolonged stay in pediatric asthma. Health Serv Res (2003) 1.26
Estimating anesthesia time using the medicare claim: a validation study. Anesthesiology (2011) 1.25
Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer (2005) 1.22
Optimal matching with minimal deviation from fine balance in a study of obesity and surgical outcomes. Biometrics (2011) 1.18
Time to send the preemie home? Additional maturity at discharge and subsequent health care costs and outcomes. Health Serv Res (2008) 1.12
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. Cancer Res (2007) 1.08
Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res (2006) 1.04
Equivalent lengths of stay of pediatric patients hospitalized in rural and nonrural hospitals. Pediatrics (2004) 1.01
ERROR-FREE MILESTONES IN ERROR PRONE MEASUREMENTS. Ann Appl Stat (2009) 0.93
Combining group-based trajectory modeling and propensity score matching for causal inferences in nonexperimental longitudinal data. Dev Psychol (2008) 0.88
Template matching for auditing hospital cost and quality. Health Serv Res (2014) 0.87
A hospital-specific template for benchmarking its cost and quality. Health Serv Res (2014) 0.86
Hypereosinophilia associated with cardiac rhabdomyosarcoma. Am J Hematol (2003) 0.83
Racial disparities in colon cancer survival: a matched cohort study. Ann Intern Med (2014) 0.83
Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol (2009) 0.82
Examining Causes of Racial Disparities in General Surgical Mortality: Hospital Quality Versus Patient Risk. Med Care (2015) 0.79
Optimizing outcomes with bevacizumab by better targeting patients and tumors. Oncology (Williston Park) (2009) 0.76
Prescribing adjuvant letrozole to patients well after the completion of tamoxifen: a good idea? Curr Oncol Rep (2009) 0.75
HER2 blockade: is combination therapy better than monotherapy? Curr Treat Options Oncol (2010) 0.75
Anesthesia technique and outcomes after hip fracture surgery--reply. JAMA (2014) 0.75
The role of MRI scanning of the contralateral breast in women with newly diagnosed breast cancer: a new care standard or not? Curr Oncol Rep (2008) 0.75
In reply. Anesthesiology (2014) 0.75
Duration of chemotherapy for early stage breast cancer: have we reached the limit? What is the survival impact of amenorrhea? Curr Treat Options Oncol (2010) 0.75
Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer. Curr Oncol Rep (2009) 0.75
Avoiding the use of anthracyclines in the adjuvant therapy of breast cancer: the "TC" (docetaxel and cyclophosphamide) regimen. Curr Oncol Rep (2008) 0.75
Practice Style Variation in Medicaid and Non-Medicaid Children With Complex Chronic Conditions Undergoing Surgery. Ann Surg (2016) 0.75